Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
04/2003
04/16/2003CN1411453A Trans olefinic glucokinase activators
04/15/2003US6548694 N-(4-carbamimidoyl-phenyl)-glycine derivatives
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/10/2003WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof
04/10/2003WO2003029198A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
04/10/2003US20030069307 Oxidation resistance; free radical scavenger; foods, drugs, cosmetics
04/10/2003CA2462675A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
04/09/2003EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003CN1105100C Compound with anti-inflammatory and immunosuppressive activities
04/08/2003US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc.
04/08/2003US6545052 Contacting skin with skin treatment composition having concentration of 1-(3-methoxybenzyl)-3-substituted thiourea compound effective for inhibiting free radical generation
04/08/2003US6545029 Antiosteoporotic, antirestenotic, anticarcinogenic and antiatherosclerotic
04/03/2003WO2003027064A1 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical co mpositions containing the same
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065176 Anticoagulant; cardiovascular disorders
04/03/2003US20030065031 Glucagon antagonists/inverse agonists
04/03/2003US20030065023 Anticancer agents, viricides, psychological disorders
04/02/2003EP1296942A1 Glucagon antagonists/inverse agonists
04/02/2003EP1296941A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/02/2003EP1296687A2 Treatment of male sexual dysfunction
04/02/2003EP0681574B1 C7 Taxane derivatives and pharmaceutical compositions containing them
04/01/2003US6541661 Inhibitors of histone deacetylase
04/01/2003US6541496 Inhibitors of IMPDH enzyme
04/01/2003US6541473 Resorcinol derivatives
03/2003
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024921A1 Alkyl urea retinoid agonists i
03/27/2003WO2003024920A1 Substituted urea retinoid agonists ii
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2002030915A3 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport
03/27/2003WO2002014261A3 4-substituted d-glutamic acid derivatives for use as antibiotic
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/26/2003EP1294682A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
03/26/2003EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/26/2003CN1103754C Carbodiimides and their preparation
03/25/2003US6538143 Reaction product of vinyl ethylene carbonate, methacryloxypropylene carbonate, and allyloxypropylene carbonate; and alkyl or cyclic urea
03/25/2003US6538094 Process for synthesis of allophanate compounds and compositions including the product thereof
03/20/2003WO2003022799A1 Ccr-3 receptor antagonists v
03/20/2003WO2002100836A8 Compounds, compositions and methods for modulating beta-amyloid production
03/20/2003WO2002051810A3 Integrin receptor ligands
03/20/2003US20030055273 Dianthraquinone compounds
03/20/2003US20030055025 For therapy of bacterial infections and neoplasms,
03/20/2003CA2459364A1 Ccr-3 receptor antagonists v
03/19/2003CN1103332C Biphenyl-5-alkanoic acid derivative and is application
03/18/2003US6534627 Synthesis and use of amino acid fluorides as peptide coupling reagents
03/18/2003US6534250 Photo-reactive benzocyclobutenones and polymers thereform for self-photocuring, photo-crosslinking and photopatterning without catalysts
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002036553A3 Substituted alkanoic acids
03/13/2003WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
03/13/2003US20030049310 Genetic enginnering; inducing antibodies
03/13/2003CA2422135A1 Urea derivatives and adhesion molecule inhibitors containing the same as effective ingredients
03/12/2003EP1289940A2 Excitatory amino acid receptor modulators
03/12/2003EP1289939A1 Phenylglycine derivatives
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531499 Matrix metalloproteinase inhibitors and method of using same
03/11/2003US6531495 Potassium channel
03/11/2003CA2242351C Novel tricyclic compounds and drug compositions containing the same
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018536A1 Chemotherapeutic agents
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003CA2457676A1 Chemotherapeutic agents
03/05/2003EP1287006A1 Antitumoral compounds
03/05/2003EP1042278B1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
03/05/2003EP0936867B1 Benzoylphenylurea insecticides and methods of using certain benzoylphenylureas to control cockroaches, ants, fleas, and termites
03/05/2003EP0796244B2 Process and plant for the production of urea with high conversion yield and low energy consumption
03/04/2003US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528499 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
02/2003
02/27/2003WO2002096884A3 Substituted benzoylketones as herbicidal agents for use as plant treatment agent
02/26/2003EP1284959A1 Compounds for modulating the rage receptor
02/25/2003US6525219 4-amino-2-hydroxy-5-substituted-acylanilide compounds and method of using them
02/25/2003US6525091 Substituted diarylureas as stimulators for Fas-mediated apoptosis
02/25/2003US6525000 N-aminoureas are reacted with formaldehyde to give methyleneimino ureas, cyclizing these to give tetrahydro-4H-1,3,4-oxa(or thia)diazines, and cyclizing the fused triazoles using phosgene; herbicides
02/25/2003US6524376 Anticorrosive agent
02/20/2003WO2003014296A2 A group of novel anti-cancer compounds with specific structure
02/20/2003WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
02/20/2003WO2002024635A3 Aminoalcohol derivatives
02/20/2003CA2456144A1 A group of novel anti-cancer compounds with specific structure
02/20/2003CA2455754A1 Amine derivatives
02/19/2003EP1284145A1 2-(3,4-Dihydroxyphenyl)ethyl substituted carbonic acid derivatives and their use
02/19/2003CN1398247A Colchinol derivatives as vascular damaging agents
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521630 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
02/17/2003CA2398112A1 2-(3,4-dihydroxyphenyl)ethyl-substituted carbonic acid derivatives and their use
02/14/2003WO2002018326A1 Novel propenohydroxamic acid derivatives
02/14/2003CA2423733A1 Novel propenohydroxamic acid derivatives
02/13/2003WO2003011223A2 Immunomodulatory compounds and methods of use thereof
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis.
02/12/2003EP1282611A1 Substituted phenylacetamides and their use as glucokinase activators
02/12/2003EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 99